Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study

被引:3
|
作者
Makita, Kenji [1 ,2 ,3 ,5 ]
Hamamoto, Yasushi [1 ]
Kanzaki, Hiromitsu [1 ]
Nagasaki, Kei [1 ]
Kozuki, Toshiyuki [4 ]
机构
[1] Natl Hosp Org, Dept Radiat Oncol, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[2] Ehime Univ, Grad Sch Med, Dept Radiol, Toon, Ehime 7910295, Japan
[3] Ehime Prefectural Cent Hosp, Dept Radiol, Matsuyama, Ehime 7900024, Japan
[4] Natl Hosp Org, Dept Thorac Oncol & Med, Shikoku Canc Ctr, Matsuyama, Ehime 7910280, Japan
[5] Natl Hosp Org, Shikoku Canc Ctr, Dept Radiat Oncol, Kou 160 Minami Umenomoto Machi, Matsuyama, Ehime 7910280, Japan
关键词
bone metastasis; lung cancer; palliative; radiotherapy; local control; TO-LYMPHOCYTE RATIO; RADIATION-THERAPY; SKELETAL METASTASES; ZOLEDRONIC ACID; CHEMOTHERAPY; INFLAMMATION; DENOSUMAB; SURVIVAL;
D O I
10.3892/ol.2023.13889
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Bone metastasis is common in advanced lung cancer, with the incidence reported to be 30%, and radiotherapy (RT) is used for pain relief from bone metastasis. The present study aimed to identify factors affecting local control (LC) of bone metastasis from lung cancer and to assess the significance of moderate RT dose escalation. This was a retrospective cohort study, where LC of bone metastasis from lung cancer that had received palliative RT was reviewed. LC at RT sites was evaluated with follow-up computed tomography (CT). The influence of treatment-, cancer- and patient-related risk factors for LC was assessed. A total of 317 metastatic lesions in 210 patients with lung cancer were evaluated. The median RT dose (biologically effective dose calculated using an alpha/beta of 10 Gy; BED10) was 39.0 Gy (range, 14.4-50.7 Gy). The median follow-up time for survival and median radiographic follow-up time were 8 (range, 1-127) and 4 (range, 1-124) months, respectively. The 0.5-year overall survival and LC rates were 58.9 and 87.7%, respectively. The local recurrence rate in RT sites was 11.0%, and bone metastatic progression, except in RT sites, was observed in 46.1% at the time of local recurrence or the last follow-up CT of the RT sites. According to multivariate analysis, RT sites, pre-RT neutrophil to lymphocyte ratio (NLR), post-RT non-administration of molecular-targeting agents (MTs), and non-administration of bone modifying agents (BMAs) were significant unfavorable factors for LC of bone metastasis. Moderate RT dose escalation (BED10 >39 Gy) tended to improve the LC of RT sites. In cases without MTs, moderate dose escalation of RT dose improved the LC of RT sites. In conclusion, treatment (post-RT MTs and BMAs), cancer (RT sites) and patient (pre-RT NLR)-related risk factors had a large impact on improving the LC of RT sites. Moderate RT dose escalation seemed to have a small impact on improving the LC of RT sites.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Outcomes of patients receiving urgent palliative radiotherapy for advanced lung cancer: an observational study
    Xu, Yang
    Trach, Celestee
    Tessier, Tracey
    Sinha, Rishi
    Skarsgard, David
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [2] Use of Palliative Chemo- and Radiotherapy at the End of Life in Patients With Cancer: A Retrospective Cohort Study
    Zhang, Zhe
    Gu, Xiao-Li
    Chen, Meng-Lei
    Liu, Ming-Hui
    Zhao, Wei-Wei
    Cheng, Wen-Wu
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2017, 34 (09) : 801 - 805
  • [3] High Fracture Risk of Femoral Bone Metastasis Treated with Palliative Radiotherapy in Recent Years
    Makita, Kenji
    Hojo, Hidehiro
    Oyoshi, Hidekazu
    Fujisawa, Takeshi
    Nakamura, Masaki
    Uchida, Gyo
    Koike, Yume
    Zhou, Yuzheng
    Tomizawa, Kento
    Fukushi, Keiko
    Zenda, Sadamoto
    CURRENT ONCOLOGY, 2024, 31 (12) : 7437 - 7444
  • [4] Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study
    Kondoh, Chihiro
    Shitara, Kohei
    Nomura, Motoo
    Takahari, Daisuke
    Ura, Takashi
    Tachibana, Hiroyuki
    Tomita, Natsuo
    Kodaira, Takeshi
    Muro, Kei
    BMC PALLIATIVE CARE, 2015, 14
  • [5] Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study
    Makita, Kenji
    Hamamoto, Yasushi
    Kanzaki, Hiromitsu
    Kataoka, Masaaki
    Yamamoto, Shuhei
    Nagasaki, Kei
    Ishikawa, Hirofumi
    Takata, Noriko
    Tsuruoka, Shintaro
    Uwatsu, Kotaro
    Kido, Teruhito
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [6] An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy
    Makita, Kenji
    Hamamoto, Yasushi
    Kanzaki, Hiromitsu
    Nagasaki, Kei
    Kozuki, Toshiyuki
    THORACIC CANCER, 2023, 14 (19) : 1795 - 1801
  • [7] The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
    Habberstad, Ragnhild
    Froseth, Trude Camilla Salvesen
    Aass, Nina
    Abramova, Tatiana
    Baas, Theo
    Morkeset, Siri Tessem
    Caraceni, Augusto
    Laird, Barry
    Boland, Jason W.
    Rossi, Romina
    Garcia-Alonso, Elena
    Stensheim, Hanne
    Loge, Jon Havard
    Hjermstad, Marianne Jensen
    Bjerkeset, Ellen
    Bye, Asta
    Lund, Jo-Asmund
    Solheim, Tora Skeidsvoll
    Vagnildhaug, Ola Magne
    Brunelli, Cinzia
    Damas, Jan Kristian
    Mollnes, Tom Eirik
    Kaasa, Stein
    Klepstad, Pal
    BMC PALLIATIVE CARE, 2018, 17
  • [8] The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
    Ragnhild Habberstad
    Trude Camilla Salvesen Frøseth
    Nina Aass
    Tatiana Abramova
    Theo Baas
    Siri Tessem Mørkeset
    Augusto Caraceni
    Barry Laird
    Jason W Boland
    Romina Rossi
    Elena Garcia-Alonso
    Hanne Stensheim
    Jon Håvard Loge
    Marianne Jensen Hjermstad
    Ellen Bjerkeset
    Asta Bye
    Jo-Åsmund Lund
    Tora Skeidsvoll Solheim
    Ola Magne Vagnildhaug
    Cinzia Brunelli
    Jan Kristian Damås
    Tom Eirik Mollnes
    Stein Kaasa
    Pål Klepstad
    BMC Palliative Care, 17
  • [9] Palliative radiotherapy: New prognostic factors for patients with bone metastasis
    Steinvoort-Draat, I. N.
    Otto-Vollaard, L.
    Quint, S.
    Tims, J. L.
    de Pree, I. M. N.
    Nuyttens, J. J.
    CANCER RADIOTHERAPIE, 2024, 28 (03): : 236 - 241
  • [10] Palliative radiotherapy utilization for cancer patients at end of life in British Columbia: retrospective cohort study
    Huang, Jin
    Wai, Elaine S.
    Lau, Francis
    Blood, Paul A.
    BMC PALLIATIVE CARE, 2014, 13